Therapy with high-doses of antithrombin III in patients with septic shock and agranulocytosis

The aim of the study was to assess efficacy of high-doses ofantithrombin 111 (AT) for treatment of septic shock in patients with an agranulocytosis. Prospective, controlled study. 29 patients from 18 to 74 years old, with blood diseases complicated with septic shock Dates of study: from 2006 to 2012...

Full description

Saved in:

Bibliographic Details
Published in:	Anesteziologiia i reanimatologiia Vol. 59; no. 4; p. 39
Main Authors:	Galstian, G M, Krechetova, A V, Troitskaia, V V, Makarova, P M, Shutova, N A, Gemdzhian, É G, Orel, E B, Kesel'man, S A, Savchenko, V G
Format:	Journal Article
Language:	Russian
Published:	Russia (Federation) 01-07-2014
Subjects:	Adolescent Adult Aged Agranulocytosis - blood Agranulocytosis - drug therapy Agranulocytosis - etiology Antithrombin III - administration & dosage Antithrombin III - adverse effects Antithrombin III - therapeutic use Antithrombins - administration & dosage Antithrombins - adverse effects Antithrombins - therapeutic use APACHE Disease-Free Survival Dose-Response Relationship, Drug Female Hematologic Diseases - complications Hematologic Diseases - drug therapy Humans Male Middle Aged Shock, Septic - blood Shock, Septic - drug therapy Shock, Septic - etiology Treatment Outcome Young Adult
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!